Recent News

• 02.17.2025 - Gil Aharon
• 01.21.2025 - UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States
• 01.21.2025 - NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States
• 01.21.2025 - NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States
• 01.13.2025 - NeurAxis Inc. Issues Letter to Shareholders
• 01.13.2025 - NeurAxis Inc. Issues Letter to Shareholders
• 01.08.2025 - NeurAxis Inc. Announces Strong Preliminary Unaudited Fourth Quarter 2024 Results; Revenues Increased 50% Year-Over-Year
• 01.08.2025 - NeurAxis Inc. Announces Strong Preliminary Unaudited Fourth Quarter 2024 Results; Revenues Increased 50% Year-Over-Year
• 01.08.2025 - NeurAxis Inc. Announces Strong Preliminary Unaudited Fourth Quarter 2024 Results; Revenues Increased 50% Year-Over-Year
• 01.06.2025 - NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Recent Filings

• 02.12.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 02.11.2025 - EFFECT Notice of Effectiveness
• 02.05.2025 - S-3/A Registration statement under Securities Act of 1933
• 01.08.2025 - 8-K Current report
• 01.08.2025 - EX-99.1 EX-99.1
• 12.13.2024 - S-3 Registration statement under Securities Act of 1933
• 12.02.2024 - SC 13D General Statement of Acquisition of Beneficial Ownership